Combining Epigenetic And Immune Therapy to Beat Cancer.

NCT04705818 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor
Advanced Colorectal Carcinoma
Advanced Soft-tissue Sarcoma
Advanced Pancreatic Adenocarcinoma
Adult Solid Tumor

Interventions

DRUG: Durvalumab
DRUG: Tazemetostat

Sponsor

Institut Bergonié

Collaborators

[object Object]
[object Object]